Mandragora

Lore & Background

In the pharmacological tradition of the empire, Mandragora occupies a place of cautious respect. Its tropane alkaloids—principally atropine, scopolamine, and hyoscyamine—act on the body's parasympathetic pathways, producing sedation, pupil dilation, and suppression of secretions at therapeutic doses, but progressing to delirium, tachycardia, and respiratory failure as the dose climbs. This narrow margin between remedy and poison makes it a favorite subject of Maomao's analysis whenever it surfaces in a case.

The plant itself is unassuming: a low, spreading herb with a thick, often forked taproot that bears a faint resemblance to a human form—a detail that has fueled centuries of folk superstition and apocryphal lore. In the palace's medical stores it is kept in sealed glass jars, labeled with the standard apothecary notation for alkaloid-rich preparations, and its dispensing is logged with the same care as any other controlled substance. The outer markets, however, are a different matter; untrained hands can easily confuse it with look-alike species or misjudge a dose.

What makes Mandragora particularly interesting in the context of the story is its versatility as both a tool and a weapon. A skilled apothecary can use its sedative and antispasmodic properties to ease a patient through a painful procedure or to quiet a feverish mind. A less scrupulous party can exploit its anticholinergic toxicity to simulate death, induce irreversible delirium, or mask the presence of a faster-acting poison by layering its effects over a longer timeline. Maomao's expertise lies precisely in reading those layered effects and peeling them apart.

Reader's Guide

Mandragora (Solanaceae; tropane-alkaloid plant). Active compounds concentrate in the root and seeds. In the palace it is stored as dried powder in sealed, logged jars; in outer markets it circulates as an unlabeled 'calming tea' or 'sleeping powder.' A poisoner might dissolve the powder in a drink or fold it into a topical balm, exploiting its slow, building onset.

Symptom timeline: oral onset 30–90 min. Early: dry mouth, blurred vision, fixed dilated pupils, dry flushed skin. Peak (2–4 h): vivid violent delirium, tachycardia, hyperthermia—the patient appears ecstatic rather than distressed, the key misdiagnosis trap. Lethal progression: respiratory depression, cardiac arrhythmia, death within 6–12 h untreated.

Maomao's treatment: she first confirms the anticholinergic toxidrome (dry mucous membranes + mydriasis + delirium) to rule out convulsant poisons. She then administers a divided-dose cholinesterase-inhibiting tincture to restore parasympathetic tone, paired with cooling, fluid replacement, and heart-rhythm monitoring while the body metabolizes the alkaloids.

Arc placement: recurring pharmacological reference, not a single-arc item. It surfaces whenever symptoms are ambiguous, when a poisoner layers its slow onset over a faster agent, or when a legitimate dose is accidentally exceeded. Flag: recurring tool.